Thailand · Delayed Price · Currency is THB Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of THB 4.79 trillion. The enterprise value is 6.26 trillion.
| Market Cap | 4.79T |
| Enterprise Value | 6.26T |
Important Dates
The last earnings date was Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Jan 23, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 66.24% |
| Float | 5.68B |
Valuation Ratios
The trailing PE ratio is 19.53 and the forward PE ratio is 9.10.
| PE Ratio | 19.53 |
| Forward PE | 9.10 |
| PS Ratio | 2.42 |
| PB Ratio | 1.63 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 25.53 |
| EV / Sales | 3.21 |
| EV / EBITDA | 7.83 |
| EV / EBIT | 10.49 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 2.41 |
| Debt / FCF | n/a |
| Interest Coverage | 7.17 |
Financial Efficiency
Return on equity (ROE) is 8.58% and return on invested capital (ROIC) is 13.68%.
| Return on Equity (ROE) | 8.58% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.68% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 24.36M |
| Profits Per Employee | 3.03M |
| Employee Count | 81,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -8.39B |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 16.20 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 63.38 |
| Average Volume (20 Days) | 212,738 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.28 |
Income Statement
In the last 12 months, Pfizer had revenue of THB 1.97 trillion and earned 245.07 billion in profits. Earnings per share was 43.03.
| Revenue | 1.97T |
| Gross Profit | 1.50T |
| Operating Income | 604.34B |
| Pretax Income | 237.19B |
| Net Income | 245.07B |
| EBITDA | 810.13B |
| EBIT | 604.34B |
| Earnings Per Share (EPS) | 43.03 |
Balance Sheet
The company has 472.61 billion in cash and 1.95 trillion in debt, with a net cash position of -1,480.73 billion.
| Cash & Cash Equivalents | 472.61B |
| Total Debt | 1.95T |
| Net Cash | -1,480.73B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.94T |
| Book Value Per Share | 514.71 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.
| Gross Margin | 75.81% |
| Operating Margin | 30.62% |
| Pretax Margin | 12.02% |
| Profit Margin | 12.42% |
| EBITDA Margin | 41.05% |
| EBIT Margin | 30.62% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.69, which amounts to a dividend yield of 4.04%.
| Dividend Per Share | 0.69 |
| Dividend Yield | 4.04% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.23% |
| Shareholder Yield | 3.82% |
| Earnings Yield | 5.12% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |